Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of clascoterone solution for androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• clascoterone (clascoterone)

Snippet

Sponsor: Cassiopea SpA | Conditions: Alopecia, Androgenetic | Phase 3 | Status: COMPLETED